# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-21-012309
Filing Date
2021-04-09
Accepted
2021-04-09 16:52:38
Documents
3
Period of Report
2021-05-26

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | nc10022188x2_def14a.htm | DEF 14A | 594436
2 |  | nc10022188x2_pc01.jpg | GRAPHIC | 599669
3 |  | nc10022188x2_pc02.jpg | GRAPHIC | 672207
| Complete submission text file | 0001140361-21-012309.txt |  | 2346841

Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-15771 | Film No.: 21818373
SIC: 2834 Pharmaceutical Preparations